Pierre Cochat
Pierre Cochat
Professeur des Universités - Praticien Hospitalier
Verified email at
Cited by
Cited by
Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters
C Glastre, P Braillon, L David, P COCHAT, PJ MEUNIER, PD DELMAS
The Journal of Clinical Endocrinology & Metabolism 70 (5), 1330-1333, 1990
Primary hyperoxaluria
P Cochat, G Rumsby
New England Journal of Medicine 369 (7), 649-658, 2013
Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus
A Doreau, A Belot, J Bastid, B Riche, MC Trescol-Biemont, B Ranchin, ...
Nature immunology 10 (7), 778-785, 2009
Human laminin β2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities
M Zenker, T Aigner, O Wendler, T Tralau, H Müntefering, R Fenski, S Pitz, ...
Human molecular genetics 13 (21), 2625-2632, 2004
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement
F Locatelli, P Bárány, A Covic, A De Francisco, L Del Vecchio, ...
Nephrology Dialysis Transplantation 28 (6), 1346-1359, 2013
European Renal Best Practice (ERBP) Transplantation guideline development group
Nephrology Dialysis Transplantation 28 (suppl_2), ii1-ii71, 2013
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy
O Gross, C Licht, HJ Anders, B Hoppe, B Beck, B Tönshoff, B Höcker, ...
Kidney international 81 (5), 494-501, 2012
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption
S Ashraf, HY Gee, S Woerner, LX Xie, V Vega-Warner, S Lovric, H Fang, ...
The Journal of clinical investigation 123 (12), 5179-5189, 2013
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
P Cochat, SA Hulton, C Acquaviva, CJ Danpure, M Daudon, M De Marchi, ...
Nephrology Dialysis Transplantation 27 (5), 1729-1736, 2012
Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1
SF Garrelfs, Y Frishberg, SA Hulton, MJ Koren, WD O’Riordan, P Cochat, ...
New England journal of medicine 384 (13), 1216-1226, 2021
Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study
B Bader-Meunier, JB Armengaud, E Haddad, R Salomon, G Deschênes, ...
The Journal of pediatrics 146 (5), 648-653, 2005
IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria
R Coppo, L Peruzzi, A Amore, A Piccoli, P Cochat, R Stone, M Kirschstein, ...
Journal of the American Society of Nephrology 18 (6), 1880-1888, 2007
Paraneoplastic glomerular diseases and malignancies
J Bacchetta, L Juillard, P Cochat, JP Droz
Critical reviews in oncology/hematology 70 (1), 39-58, 2009
Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study
D Mekahli, A Liutkus, B Ranchin, A Yu, L Bessenay, E Girardin, ...
Pediatric nephrology 24, 1525-1532, 2009
A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin
K Dahan, O Devuyst, M Smaers, D Vertommen, G Loute, JM Poux, B Viron, ...
Journal of the American Society of Nephrology 14 (11), 2883-2893, 2003
Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults
A Brodin-Sartorius, MJ Tête, P Niaudet, C Antignac, G Guest, C Ottolenghi, ...
Kidney international 81 (2), 179-189, 2012
Nephropathic cystinosis: an international consensus document
F Emma, G Nesterova, C Langman, A Labbé, S Cherqui, P Goodyer, ...
Nephrology Dialysis Transplantation 29 (suppl_4), iv87-iv94, 2014
Epidemiology of primary hyperoxaluria type 1
P Cochat, A Deloraine, M Rotily, F Olive, I Liponski, N Deries, ...
Nephrology Dialysis Transplantation 10 (supp8), 3-7, 1995
Mutations in the human laminin β2 (LAMB2) gene and the associated phenotypic spectruma
V Matejas, B Hinkes, F Alkandari, L Al‐Gazali, E Annexstad, MB Aytac, ...
Human mutation 31 (9), 992-1002, 2010
Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria
B Hoppe, JW Groothoff, SA Hulton, P Cochat, P Niaudet, MJ Kemper, ...
Nephrology Dialysis Transplantation 26 (11), 3609-3615, 2011
The system can't perform the operation now. Try again later.
Articles 1–20